Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04128761 · ClinicalTrials.gov registry record · NA
Decreasing the Temporal Window in Individuals With Alcohol Use Disorder
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT04128761 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 124 participants.
The verdict
NCT04128761, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
In the absence of sufficient monetary resources, individuals must attend to immediate, minimum needs (e.g., food, shelter). This constricts one's temporal window and engenders neglect of the future. In observational studies, scarcity is associated with higher rates of delay discounting. Additionally, socioeconomic status is inversely associated with alcohol use disorder and related problems. Experimentally, scarcity shortens attention, impedes cognitive function, and increases delay discounting in multiple populations. Moreover, scarcity increases demand for fast foods in the obese and increases craving for alcohol in problem drinkers. These data suggest that economic scarcity worsens both components of reinforcer pathology (delay discounting and alcohol overvaluation), thus increasing vulnerability to alcohol use disorder. However, studies investigating the effects of scarcity on alcohol demand discounting rate have been limited. The purpose of Aim 1b is to examine effects of decreasing the temporal window and its concomitant effects on alcohol valuation (demand, and craving) and delay discounting.
Interventions
- BEHAVIORAL Scarcity Narrative
- BEHAVIORAL Neutral Narrative
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2024-05-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04128761
The ClinicalTrials.gov registry entry for NCT04128761 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Scarcity Narrative is the first listed.
NCT04128761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04128761 about?
NCT04128761 is a clinical study titled "Decreasing the Temporal Window in Individuals With Alcohol Use Disorder". In the absence of sufficient monetary resources, individuals must attend to immediate, minimum needs (e.g., food, shelter). This constricts one's temporal window and engenders neglect of the future. In observational studies, scarcity is associated with higher rates of delay discounting. Additionally...
What is the current status of trial NCT04128761?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2023-09-21. Estimated completion is 2024-05-28.
What interventions are being tested in trial NCT04128761?
The interventions under investigation include: Scarcity Narrative (BEHAVIORAL), Neutral Narrative (BEHAVIORAL).
Who is sponsoring clinical trial NCT04128761?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.